How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper

Eva Neumann, Filippa Schreeck, Jethro Herberg, Evelyne Jacqz Aigrain, Anke H. Maitland-van der Zee, Antonio Pérez-Martínez, Daniel B. Hawcutt, Elke Schaeffeler, Anders Rane, Saskia N. de Wildt, Matthias Schwab*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

6 Citations (Scopus)
58 Downloads (Pure)

Fingerprint

Dive into the research topics of 'How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology